Role of PKR and type I IFNs in viral control during primary and secondary infection

PLoS Pathogens

Volumn 6, Issue 6, 2010, Pages

  Nakayama, Yumi ^a   Plisch, Erin H ^a   Sullivan, Jeremy ^a   Thomas, Chester ^a   Czuprynski, Charles J ^a   Williams, Bryan R G ^b   Suresh, M ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PROTEIN KINASE R; RLM GP33; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; HOMEODOMAIN PROTEIN; MESSENGER RNA; RAG 1 PROTEIN; RAG-1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE EXPRESSION; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIMARY INFECTION; SECONDARY INFECTION; SIGNAL TRANSDUCTION; VACCINIA VIRUS; VIRUS INFECTION; VIRUS INHIBITION; VIRUS LOAD; VIRUS RECOMBINANT; VIRUS REPLICATION; ANIMAL; C57BL MOUSE; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LISTERIA MONOCYTOGENES; LISTERIOSIS; LYMPHOCYTIC CHORIOMENINGITIS; MALE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VACCINIA; VIROLOGY; WESTERN BLOTTING;

LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MUS; VACCINIA VIRUS;

ANIMALS; BLOTTING, WESTERN; CD8-POSITIVE T-LYMPHOCYTES; EIF-2 KINASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HOMEODOMAIN PROTEINS; IMMUNOLOGIC MEMORY; INTERFERON TYPE I; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC; VACCINIA; VACCINIA VIRUS; VIRUS REPLICATION;

EID: 77954674891     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000966     Document Type: Article

References (61)

1. Beutler B (2004) Innate immunity: an overview. Mol Immunol 40: 845-859.
2. Barber GN (2001) Host defense, viruses and apoptosis. Cell Death Differ 8: 113-126.
3. Sadler AJ, Williams BR (2008) Interferon-inducible antiviral effectors. Nat Rev Immunol 8: 559-568.
4. Biron CA (2001) Interferons alpha and beta as immune regulators-a new look. Immunity 14: 661-664.
5. Havenar-Daughton C, Kolumam GA, Murali-Krishna K (2006) Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection. J Immunol 176: 3315-3319.
6. Kolumam GA, Thomas S, Thompson LJ, Sprent J, Murali-Krishna K (2005) Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection. J Exp Med 202: 637-650.
7. Le Bon A, Tough DF (2008) Type I interferon as a stimulus for cross-priming. Cytokine Growth Factor Rev 19: 33-40.
8. Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, et al. (1998) Type I IFNs enhance the terminal differentiation of dendritic cells. J Immunol 161: 1947-1953.
9. Sen GC, Peters GA (2007) Viral stress-inducible genes. Adv Virus Res 70: 233-263.
10. Samuel CE (2001) Antiviral actions of interferons. Clin Microbiol Rev 14: 778-809, table of contents.
11. Sadler AJ, Williams BR (2007) Structure and function of the protein kinase R. Curr Top Microbiol Immunol 316: 253-292.
12. Katze MG (1992) The war against the interferon-induced dsRNA-activated protein kinase: can viruses win? J Interferon Res 12: 241-248.
13. Katze MG (1995) Regulation of the interferon-induced PKR: can viruses cope? Trends Microbiol 3: 75-78.
14. Katze MG, He Y, Gale M, Jr. (2002) Viruses and interferon: a fight for supremacy. Nat Rev Immunol 2: 675-687.
15. Langland JO, Cameron JM, Heck MC, Jancovich JK, Jacobs BL (2006) Inhibition of PKR by RNA and DNA viruses. Virus Res 119: 100-110.
16. Cuddihy AR, Li S, Tam NW, Wong AH, Taya Y, et al. (1999) Double-stranded- RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. Mol Cell Biol 19: 2475-2484.
17. Cuddihy AR, Wong AH, Tam NW, Li S, Koromilas AE (1999) The double- stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene 18: 2690-2702.
18. Grolleau A, Kaplan MJ, Hanash SM, Beretta L, Richardson B (2000) Impaired translational response and increased protein kinase PKR expression in T cells from lupus patients. J Clin Invest 106: 1561-1568.
19. Hsu LC, Park JM, Zhang K, Luo JL, Maeda S, et al. (2004) The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 428: 341-345.
20. Kadereit S, Xu H, Engeman TM, Yang YL, Fairchild RL, et al. (2000) Negative regulation of CD8+ T cell function by the IFN-induced and double-stranded RNA-activated kinase PKR. J Immunol 165: 6896-6901.
21. Garcia MA, Meurs EF, Esteban M (2007) The dsRNA protein kinase PKR: virus and cell control. Biochimie 89: 799-811.
22. Goh KC, deVeer MJ, Williams BR (2000) The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J 19: 4292-4297.
23. Suresh M, Singh A, Fischer C (2005) Role of tumor necrosis factor receptors in regulating CD8 T-cell responses during acute lymphocytic choriomeningitis virus infection. J Virol 79: 202-213.
24. Tewari K, Nakayama Y, Suresh M (2007) Role of direct effects of IFN-gamma on T cells in the regulation of CD8 T cell homeostasis. J Immunol 179: 2115-2125.
25. van den Broek MF, Muller U, Huang S, Zinkernagel RM, Aguet M (1995) Immune defence in mice lacking type I and/or type II interferon receptors. Immunol Rev 148: 5-18.
26. van den Broek MF, Muller U, Huang S, Aguet M, Zinkernagel RM (1995) Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J Virol 69: 4792-4796.
27. Alsharifi M, Mullbacher A, Regner M (2008) Interferon type I responses in primary and secondary infections. Immunol Cell Biol 86: 239-245.
28. Khanolkar A, Fuller MJ, Zajac AJ (2002) T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus. Immunol Res 26: 309-321.
29. Kumar A, Haque J, Lacoste J, Hiscott J, Williams BR (1994) Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci U S A 91: 6288-6292.
30. Biron CA, Nguyen KB, Pien GC (2002) Innate immune responses to LCMV infections: natural killer cells and cytokines. Curr Top Microbiol Immunol 263: 7-27.
31. Offermann MK, Zimring J, Mellits KH, Hagan MK, Shaw R, et al. (1995) Activation of the double-stranded-RNA-activated protein kinase and induction of vascular cell adhesion molecule-1 by poly (I).poly (C) in endothelial cells. Eur J Biochem 232: 28-36.
32. Kaech SM, Wherry EJ (2007) Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 27: 393-405.
33. Hansen SG, Vieville C, Whizin N, Coyne-Johnson L, Siess DC, et al. (2009) Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 15: 293-299.
34. Huster KM, Stemberger C, Busch DH (2006) Protective immunity towards intracellular pathogens. Curr Opin Immunol 18: 458-464.
35. Stemberger C, Huster KM, Busch DH (2006) Defining correlates of T cell protection against infection. Discov Med 6: 148-152.
36. Stemberger C, Neuenhahn M, Buchholz VR, Busch DH (2007) Origin of CD8+ effector and memory T cell subsets. Cell Mol Immunol 4: 399-405.
37. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, et al. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
38. Rodriguez JR, Rodriguez D, Esteban M (1991) Interferon treatment inhibits early events in vaccinia virus gene expression in infected mice. Virology 185: 929-933.
39. Williams BR (2001) Signal integration via PKR. Sci STKE 2001: RE2.
40. Samuel CE (1993) The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. J Biol Chem 268: 7603-7606.
41. Yeung MC, Chang DL, Camantigue RE, Lau AS (1999) Inhibitory role of the host apoptogenic gene PKR in the establishment of persistent infection by encephalomyocarditis virus in U937 cells. Proc Natl Acad Sci U S A 96: 11860-11865.
42. Yeung MC, Lau AS (1998) Tumor suppressor p53 as a component of the tumor necrosis factor-induced, protein kinase PKR-mediated apoptotic pathway in human promonocytic U937 cells. J Biol Chem 273: 25198-25202.
43. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, et al. (2003) Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 8: 237-249.
44. Nallagatla SR, Hwang J, Toroney R, Zheng X, Cameron CE, et al. (2007) 59- triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science 318: 1455-1458.
45. Shen H, Slifka MK, Matloubian M, Jensen ER, Ahmed R, et al. (1995) Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci U S A 92: 3987-3991.
46. Ryman KD, White LJ, Johnston RE, Klimstra WB (2002) Effects of PKR/ RNase L-dependent and alternative antiviral pathways on alphavirus replication and pathogenesis. Viral Immunol 15: 53-76.
47. Park JH, Yu Q, Erman B, Appelbaum JS, Montoya-Durango D, et al. (2004) Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival. Immunity 21: 289-302.
48. Yamaji K, Nabeshima S, Murata M, Chong Y, Furusyo N, et al. (2006) Interferon-alpha/beta upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-alpha/beta treatment. Cancer Immunol Immunother 55: 394-403.
49. Nguyen KB, Salazar-Mather TP, Dalod MY, Van Deusen JB, Wei XQ, et al. (2002) Coordinated and distinct roles for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 169: 4279-4287.
50. Durbin JE, Fernandez-Sesma A, Lee CK, Rao TD, Frey AB, et al. (2000) Type I IFN modulates innate and specific antiviral immunity. J Immunol 164: 4220-4228.
51. Zhang X, Sun S, Hwang I, Tough DF, Sprent J (1998) Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8: 591-599.
52. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, et al. (2005) Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434: 243-249.
53. Honda K, Taniguchi T (2006) IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol 6: 644-658.
54. Takaoka A, Yanai H (2006) Interferon signalling network in innate defence. Cell Microbiol 8: 907-922.
55. Perdiguero B, Esteban M (2009) The interferon system and vaccinia virus evasion mechanisms. J Interferon Cytokine Res 29: 581-598.
56. Yang YL, Reis LF, Pavlovic J, Aguzzi A, Schafer R, et al. (1995) Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. Embo J 14: 6095-6106.
57. Ahmed R, Salmi A, Butler LD, Chiller JM, Oldstone MB (1984) Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence. J Exp Med 160: 521-540.
58. Whitton JL, Southern PJ, Oldstone MB (1988) Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology 162: 321-327.
59. Murali-Krishna K, Altman JD, Suresh M, Sourdive DJ, Zajac AJ, et al. (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8: 177-187.
60. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, et al. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176: 1693-1702.
61. Miller NE, Bonczyk JR, Nakayama Y, Suresh M (2005) Role of thymic output in regulating CD8 T-cell homeostasis during acute and chronic viral infection. J Virol 79: 9419-9429.